Navigation Links
Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
Date:12/3/2007

automation and imaging elements of Caliper's business. Drug combination studies can show whether chemical entities improve the efficacy of existing standard care treatments, providing a possible catalyst to FDA approval and market adoption. Testing combinations in vitro and in vivo also ensures that new clinical compounds will not decrease the effectiveness of standard therapy, thereby avoiding potentially harmful consequences for human study subjects. Drug combination studies also allow clinicians to better optimize the doses used in clinical trials as well.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of leading-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
(Date:3/27/2015)... Wis. , March 27, 2015 ... unit shipments of incontinence devices for women. ... but the most gratifying part is the hundreds ... from women whose lives have been positively impacted ... president of InControl. InControl recently released ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Feb. 8, 2011 Targetbase ... for its expertise in understanding consumer data, translating that ... creative with measurable results, today announced that Peter Dannenfelser ... - Healthcare.  Dannenfelser, a pharmaceutical marketing executive with extensive ...
... Canon announced today at MD&M West in Anaheim that it ... build on its success since its 2010 launch. As part ... (CDM) database product will become part of Qmed, the world,s ... medical device OEMs. As part of the new alignment, the ...
Cached Medicine Technology:Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience 2Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience 3UBM Canon Announces Significant Investment and Development Plans for the Next Generation of Qmed.com 2UBM Canon Announces Significant Investment and Development Plans for the Next Generation of Qmed.com 3
(Date:3/27/2015)... 2015 GenSight, the leading Enterprise Portfolio ... Fitzgerald, a former technology and financial executive to serve ... Chief Financial Officer. , Mr Fitzgerald was most recently ... backed by Amazon founder and CEO Jeff Bezos, Google ... to EverFi, he was a Senior Vice President at ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Operatic contenders ... of greatness on April 17th. The universally acclaimed baritone ... the 9th annual Opera Idol at The Merion in ... competition, which has drawn aspiring opera singers from around ... showcases some of the finest young talent in the ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... 2015 “ VXi BlueParott Reveal ” ... Tech Report, which features the latest and coolest technology ... and special reporter for NewsWatch, conducted the review and ... headset, eliminating 90% of ambient noise. , Today, business ... emails are important to any professional, voice calls are ...
(Date:3/26/2015)... TX (PRWEB) March 27, 2015 Moreno ... proud to announce prestigious victories at the 2015 International ... ranch was quite successful across many categories of show ... our performance at the ABBA International Brahman show,” explained ... friendly competition, and the proof of our superior genetics ...
Breaking Medicine News(10 mins):Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2
... Michael O'Donovan at Cardiff University// have discovered the gene which ... An analysis of 300 families where at least one ... The gene has been called "KIAA0319". ,"This is ... gene which contributes to susceptibility to the common form of ...
... the liver and can cause complications such as liver ... B vaccine is recommended for infants. Previous research has ... for up to 10 years. However, a recent study ... ,Researchers followed eight-hundred-and-forty-one Alaska natives vaccinated with three ...
... by researchers, brain stimulation may help depressive patients, when ... result on them. ,People suffering from sustained ... stimulation of their brains, when other medication were not ... brain associated with depressive feelings have shown a noticeable ...
... to children suffering from attention deficit hyperactivity disorder (ADHD), had ... the drug Ritalin, in the past, had been linked to ... time any study links the drug to cancer proneness in ... of Preventive Medicine and Community Health, The University of Texas, ...
... latest issue of Harvard Heart Letter, testing of eyes may ... of eye can predict the condition of the heart, kidneys ... study headed by Dr. John I. Loewenstein, a retina specialist ... been drawn between changing conditions of blood vessels inside the ...
... of the American Academy of Orthopedic Surgeons in Washington, D.C. ... the result of several problems other than anatomical, and not ... a surgery. The study that had observed about 6000 surgical ... said that patients who had other health troubles than back ...
Cached Medicine News:
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Shandon MicroWriter™ I Cassette Labeler is a permanent cassette marking system....
Fully modular system for long-term storage. Available as complete five-drawer system or as individual components....
Space-saving storage cabinets for microscope slides....
Medicine Products: